Vein External Support Trial (VEST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01415245 |
Recruitment Status :
Completed
First Posted : August 11, 2011
Last Update Posted : May 20, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Coronary Heart Disease | Device: Fluent (VGS Fluent external support device) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Vein External Support Trial |
Study Start Date : | October 2011 |
Actual Primary Completion Date : | September 2013 |
Actual Study Completion Date : | December 2013 |
Arm | Intervention/treatment |
---|---|
Experimental: Treatment
Device applied to saphenous vein graft
|
Device: Fluent (VGS Fluent external support device)
Fluent external support device applied to saphenous vein graft |
No Intervention: Control
Saphenous vein graft without device support
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Primary Inclusion Criteria:
- Patient scheduled for on-pump CABG on clinical grounds
- Vein grafts indicated for right and circumflex coronary arteries and LIMA indicated for the LAD on clinical grounds
- Native circumflex and right coronary arteries have at least one stenosis in each vessel> 75%
Primary Exclusion Criteria:
- Concomitant non-CABG cardiac procedure
- Prior peripheral vascular or cardiac surgery
- Emergency CABG surgery (cardiogenic shock, inotrophic pressure support, IABP)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01415245
United Kingdom | |
Royal Brompton Hospital | |
London, United Kingdom | |
Harefield Hospital | |
Middlesex, United Kingdom | |
The John Radcliffe Hospital | |
Oxford, United Kingdom |
Responsible Party: | Vascular Graft Solutions Ltd. |
ClinicalTrials.gov Identifier: | NCT01415245 |
Other Study ID Numbers: |
CI-01-01 |
First Posted: | August 11, 2011 Key Record Dates |
Last Update Posted: | May 20, 2014 |
Last Verified: | May 2014 |
Heart Diseases Coronary Disease Coronary Artery Disease Myocardial Ischemia |
Cardiovascular Diseases Vascular Diseases Arteriosclerosis Arterial Occlusive Diseases |